期刊文献+

TaqMan实时荧光定量逆转录聚合酶链反应在强直性脊柱炎IL-2RαmRNA检测的应用价值

Quantitative Analysis of Interleukine-2 Receptor α mRNA Expression in Ankylosing Sondylitis by Fluorescence Quantitative Reverse Transcription Polymerase Chain Reaction and Clinical Significance
下载PDF
导出
摘要 目的:利用TaqMan实时荧光定量逆转录聚合酶链反应(FQ-RT-PCR)检测强直性脊柱炎患者外周血单个核细胞白细胞介素-2受体α(IL-2Rα)mRNA的表达水平,并进行疾病的活动性相关分析。方法:用 Primer Express v2.0软件,根据GenBank提供的序列,在人IL-2Rα mRNA的第2和第3外显子之间设计一对引物和一条TaqMan探针。提取总RNA,加入已优化的一步法FQ-RT-PCR反应体系,扩增产物经凝胶电泳后切胶回收,并与pUCm-T载体连接。制备好的重组质粒转化感受态细胞进行克隆。经测序分析确定为特异性片段后,用T7RNA聚合酶转录为cRNA,作为FQ-RT-PCR系列浓度标准品。评价FQ-RT-PCR检测 IL-2Rα mRNA的特异性、线性、精密度和探针稳定性等。定量测定HLA-B27阳性活动组与阴性非活动组强直性脊柱炎患者外周血单个核细胞IL-2Rα mRNA基因的表达水平,结合血浆可溶性白细胞介素-2受体 (sIL-2R)浓度,探讨与炎症活动的相互关系。结果:成功构建了cRNA标准品。该方法的线性范围为7~107 cells/ml,其批内CV8.4%,批间CV9.6%;扩增产物克隆的双向测序结果经BLAST比较、分析,证实为IL- 2Rα mRNA特异性片段。对各30例HLA-B27阳性与阴性的强直性脊柱炎的测定表明:与正常人对照组结果比较,HLA-B27阳性组与HLA-B27阴性组IL-2Rα mRNA和sIL-2R都有明显增加(P<0.01)。IL-2Rα mRNA对炎症活动评价的灵敏度为96.7%。结论:FQ-RT-PCR具有灵敏、特异、结果重复性好等优点;IL- 2Rα mRNA与sIL-2R比较更能反映强直性脊柱炎患者的免疫状态,可能为免疫药物的疗效评价和药物筛选提供基因表达水平上的信息。 Objective:To construct and evaluate real-time fluorescence quantitative poiymerase chain reaction for detecting IL-2Ra mRNA in ankylosing sondylitis(AS) on TaqMan technique. Methods: A pair of primers and a probe with MGB were designed by Primer EXPress V2. O software program . Using the peripheral blood monocytes (PBMC) of homo sapiens as samples , total RNA was isolated from fresh PBMC . RNA was amplified by the real-time FQ-RT-PCR. The specificy of the recombined plasmid was tested by agarose gel eletrophoresis and sequencing analysis . IL-2Rα recombined plasmid was transcribed to cRNA by T7 RNA poiymerase for Serial Standard materials of FQ-RT-PCR. A new method was created to quantify IL-2Rα mRNA in ideal condition sensitivity, reproducibity and efficiency of the FQ-RT-PCR was evaluated and used ,combined with sIL-2R,for clinical application of AS. Results:Minimum limit of FQ-RT-PCR system was 7cells/ml and linear range from (7-107)cells/ml . The intra-and-inter-assay cofficient variation(CV) was 8. 4% and 9. 6% respectively. Recombined plasmid contained the target fragment was specificity and accuracy by BLAST. Standard reference was constructed successfully. RT-PCR product in AS with HLA-B27 positive groups were higher than HLA-B27 negtive groupsand health controls (P <0. 01), HLA-B27 negtive groups and HLA-B27 positive groups were not different (P >0. 05) . The sensitivity of IL-2Rα mRNA was 96. 7%. Conciusions:Real Time FQ-RT-PCR of JL-2Rα mRNA is constructed successfully. This is easy, rapid and more sensitive , accurate and reliable method for quantifing IL-2Rα mRNA. There is highly statistical significance,compared with sIL-2R ,on the expression of IL-2Rα mRNA and inflammatory states between AS and control group and effective information for adminstration of patients.
出处 《检验医学教育》 2005年第1期36-40,共5页
  • 相关文献

参考文献3

二级参考文献19

  • 1Allan S M, Harrison D C, Read S, et al. Selective increases in cytokine expression in the rat brain in response to striatal injection of a-amino-3-hydroxy-5-methyl-4-isoxazolepropionate and interleukin-1.Molecular Brain Research, 2001, 93 (2): 180-189. 被引量:1
  • 2Bustin S A. Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J Mol Endocrinol, 2000, 25 (2): 169-193. 被引量:1
  • 3Giulietti A, Overbergh L, Valckx D, et al. An overview of real-time quantitative PCR: applications to quantify cytokine gene expression. Methods, 2001, 25 (4): 386-401. 被引量:1
  • 4Fronhoffs S, Totzke G, Stier S, et al. A method for the rapid construction of cRNA standard curve in quantitative real-time reverse transcrition polymerase chain reaction. Molecular and Cellular Probes, 2002, 16 (2): 99-110. 被引量:1
  • 5McGonagle D, Benjamin M, Marzo-Ortega H, et al. Advances in the understanding of entheseal inflammation, Curt Rheumatol Rep, 2002,4: 500-506. 被引量:1
  • 6Beutler BA. The role of ttanor necrosis factor in health and diseaes. J Rheumatol, 1999,27:16-21. 被引量:1
  • 7Brandt J,Haibel H,Cornely D,et al. Successful treatment of active ankylosing spondylitis with the anti-ttanor necrosis factor a monclonal antibody "infliximab. Arthritis Rheum, 2000,43 : 1346-1352. 被引量:1
  • 8Braun J, Brandt J, Listin J, et al. Treatment of active ankylosing spondylitis with infliximab: a randomized controlled multicenter trial. Lancet, 2002,359:1187-1193. 被引量:1
  • 9Van den Bosch F, Kruithof D, Baeten F, et al. Effects of a loading dose regimen of three infusions of chimeric monoclonal antibody to tumour necrosis factor alpha (infliximab) in spondyloarthropathy: an open pilot study see (comments). Ann Rheum Dis, 2000, 59:428. 被引量:1
  • 10Panayi GS, Corrigall VM, Pitzalis C. Pathogenesis of rheumatoid arthritis:the role of T cells and other beasts. Rheum Dis Clin North Am, 2001,27:317-334. 被引量:1

共引文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部